To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

NCT04761731 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: ADVAGRAF®

Sponsor

Linical Korea

Collaborators

[object Object]
[object Object]